These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 25433949)
1. Polymorphism of DNA methyltransferase 3B -149C/T and cancer risk: a meta-analysis. Zhu J; Du S; Zhang J; Wang Y; Wu Q; Ni J Med Oncol; 2015 Jan; 32(1):399. PubMed ID: 25433949 [TBL] [Abstract][Full Text] [Related]
2. DNMT3B -149 C>T and -579 G>T Polymorphisms and Risk of Gastric and Colorectal Cancer: a Meta-analysis. Khoram-Abadi KM; Forat-Yazdi M; Kheirandish S; Saeidi N; Zarezade Z; Mehrabi N; Neamatzadeh H Asian Pac J Cancer Prev; 2016; 17(6):3015-20. PubMed ID: 27356727 [TBL] [Abstract][Full Text] [Related]
3. Genetic polymorphism of DNA methyltransferase 3B 149 C>T and risk of colorectal cancer: a meta-analysis. Meng Q; Zhang J; Lian B; Song C Tumour Biol; 2014 Mar; 35(3):2367-72. PubMed ID: 24178910 [TBL] [Abstract][Full Text] [Related]
4. DNA methyltransferase 3B -149C/T polymorphism and the risk of laryngeal squamous cell carcinoma: a case-control study. Zhang XM; Li S; Zhang QM Genet Mol Res; 2015 Oct; 14(4):12866-71. PubMed ID: 26505438 [TBL] [Abstract][Full Text] [Related]
5. The -149C>T polymorphism of DNMT3B is not associated with colorectal cancer risk: Evidence from a meta-analysis based on case-control studies. Fang C; Sun W; Han H; Shi L; Wang L; Zhao Y; Tan Y Exp Ther Med; 2012 Oct; 4(4):728-732. PubMed ID: 23170134 [TBL] [Abstract][Full Text] [Related]
6. Polymorphism of vascular endothelial growth factor -2578C/A with cancer risk: evidence from 11263 subjects. Cao C; Ying T; Fang JJ; Sun SF; Lv D; Chen ZB; Ma HY; Yu YM; Ding QL; Shu LH; Deng ZC Med Oncol; 2011 Dec; 28(4):1169-75. PubMed ID: 20635170 [TBL] [Abstract][Full Text] [Related]
7. Single nucleotide polymorphism in DNMT3B promoter and its association with hepatocellular carcinoma in a Moroccan population. Ezzikouri S; El Feydi AE; Benazzouz M; Afifi R; El Kihal L; Hassar M; Akil A; Pineau P; Benjelloun S Infect Genet Evol; 2009 Sep; 9(5):877-81. PubMed ID: 19465161 [TBL] [Abstract][Full Text] [Related]
8. Associations of DNMT3B -149C>T and -2437T>A polymorphisms and lung cancer risk in Chinese population. Gao M; He D; Meng F; Li J; Shen Y World J Surg Oncol; 2016 Nov; 14(1):293. PubMed ID: 27876061 [TBL] [Abstract][Full Text] [Related]
9. The DNMT3B -579G>T Polymorphism Is Significantly Associated With the Risk of Gastric Cancer but not Lung Cancer in Chinese Population. Chen B; Wang J; Gu X; Zhang J; Zhang J; Feng X Technol Cancer Res Treat; 2017 Dec; 16(6):1259-1265. PubMed ID: 29332452 [TBL] [Abstract][Full Text] [Related]
10. Polymorphism of DNA Methyltransferase 3b and Association with Development and Prognosis in Gastric Cancer. Wang C; Jia Z; Cao D; You L; Jin M; Wu X; Wen S; Cao X; Jiang J PLoS One; 2015; 10(8):e0134059. PubMed ID: 26262893 [TBL] [Abstract][Full Text] [Related]
11. The MDM2 309 T/G polymorphism is associated with head and neck cancer risk especially in nasopharyngeal cancer: a meta-analysis. Zhang Y; Bai Y; Zhang Y; Guan J; Chen L Onkologie; 2012; 35(11):666-70. PubMed ID: 23147543 [TBL] [Abstract][Full Text] [Related]
12. Association of a tgf-b1-509c/t polymorphism with gastric cancer risk: a meta-analysis. Li K; Xia F; Zhang K; Mo A; Liu L Ann Hum Genet; 2013 Jan; 77(1):1-8. PubMed ID: 23088218 [TBL] [Abstract][Full Text] [Related]
13. Association between mitogen-activated protein kinase kinase kinase 1 rs889312 polymorphism and breast cancer risk: evidence from 59,977 subjects. Lu PH; Yang J; Li C; Wei MX; Shen W; Shi LP; Jiang ZY; Zhou N; Tao GQ Breast Cancer Res Treat; 2011 Apr; 126(3):663-70. PubMed ID: 20809358 [TBL] [Abstract][Full Text] [Related]
14. Tumour necrosis factor alpha -308G/A polymorphism and risk of the four most frequent cancers: a meta-analysis. Wang J; Cao C; Luo H; Xiong S; Xu Y; Xiong W Int J Immunogenet; 2011 Aug; 38(4):311-20. PubMed ID: 21624061 [TBL] [Abstract][Full Text] [Related]
15. DNMT3B polymorphisms and risk of primary lung cancer. Lee SJ; Jeon HS; Jang JS; Park SH; Lee GY; Lee BH; Kim CH; Kang YM; Lee WK; Kam S; Park RW; Kim IS; Cho YL; Jung TH; Park JY Carcinogenesis; 2005 Feb; 26(2):403-9. PubMed ID: 15528220 [TBL] [Abstract][Full Text] [Related]
16. DNMT3b -149C/T promoter variants and methylation of colorectal cancer-associated genes. Naghibalhossaini F; Mokarram P; Khalili E; Naghibalhossaini S Cancer Biomark; 2015; 15(3):227-33. PubMed ID: 25769449 [TBL] [Abstract][Full Text] [Related]
17. Gene expression and promoter polymorphisms of DNA methyltransferase 3B in nasopharyngeal carcinomas in Taiwanese people: a case-control study. Chang KP; Hao SP; Tsang NM; Chang YL; Cheng MH; Liu CT; Lee YS; Tsai CL; Lee TJ; Wang TH; Tsai CN Oncol Rep; 2008 Jan; 19(1):217-22. PubMed ID: 18097598 [TBL] [Abstract][Full Text] [Related]
18. Maternal risk for down syndrome and polymorphisms in the promoter region of the DNMT3B gene: a case-control study. Jaiswal SK; Sukla KK; Kumari N; Lakhotia AR; Kumar A; Rai AK Birth Defects Res A Clin Mol Teratol; 2015 Apr; 103(4):299-305. PubMed ID: 25656965 [TBL] [Abstract][Full Text] [Related]
19. Genetic and epigenetic variation in the DNMT3B and MTHFR genes and colorectal adenoma risk. Ho V; Ashbury JE; Taylor S; Vanner S; King WD Environ Mol Mutagen; 2016 May; 57(4):261-8. PubMed ID: 27062459 [TBL] [Abstract][Full Text] [Related]
20. Promoter polymorphisms of DNMT3B and the risk of head and neck squamous cell carcinoma in Taiwan: a case-control study. Chang KP; Hao SP; Liu CT; Cheng MH; Chang YL; Lee YS; Wang TH; Tsai CN Oral Oncol; 2007 Apr; 43(4):345-51. PubMed ID: 16920385 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]